Microbix Biosystems (TSX:MBX) ROCE %: -14.50% (As of Mar. 2026)

What is Microbix Biosystems ROCE %?

Microbix Biosystems TSX:MBX +5.17% 52 ROCE % is -14.50% as of Mar. 2026. GuruFocus rates TSX:MBX with a GF Score™ of 52/100 and a GF Value™ of C$0.24 (Modestly Overvalued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Microbix Biosystems's annualized ROCE % for the quarter that ended in Mar. 2026 was -14.50%.

Microbix Biosystems (TSX:MBX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Microbix Biosystems ROCE % Related Terms

Microbix Biosystems ROCE % Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems ROCE % Chart

Microbix Biosystems Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

ROCE %

Get a 7-Day Free Trial

27.53

9.95

2.59

13.92

-3.90

Microbix Biosystems Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															3.02	-15.67	-14.69	-10.74	-14.50

52GF Score

Microbix Biosystems Inc TSX:MBX

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Microbix Biosystems ROCE % Calculation

Microbix Biosystems's annualized ROCE % for the fiscal year that ended in Sep. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2025 )		(A: Sep. 2024 )		(A: Sep. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2025 )		(A: Sep. 2024 )		(A: Sep. 2025 )
	=	-1.351	/	( ( (38.097 - 3.395)	+	(37.41 - 2.779) )	/ 2 )
	=	-1.351	/	( (34.702	+	34.631)	/ 2 )
	=	-1.351	/	34.6665
	=	-3.90 %

Microbix Biosystems's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	-4.696	/	( ( (36.591 - 3.067)	+	(35.365 - 4.118) )	/ 2 )
	=	-4.696	/	( ( 33.524	+	31.247 )	/ 2 )
	=	-4.696	/	32.3855
	=	-14.50 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of -14.50% mean?

Microbix Biosystems (TSX:MBX) has a ROCE % of -14.50% as of Mar. 2026.

Is Microbix Biosystems' ROCE % too high?

Microbix Biosystems' current ROCE % is -14.50%. Overall, Microbix Biosystems has a GF Score™ of 52/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Microbix Biosystems' ROCE % compare to VRTX and REGN?

Microbix Biosystems' ROCE % of -14.50% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Biotechnology company?

A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Microbix Biosystems's current ROCE % is -14.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Microbix Biosystems stock overvalued right now?

Based on GuruFocus' analysis, Microbix Biosystems (TSX:MBX) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.24, compared to a current price of C$0.31 — trading 27.1% above its estimated fair value. The current ROCE % is -14.50%. Microbix Biosystems' overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Microbix Biosystems (TSX:MBX), the current ROCE % is -14.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (TSX:MBX) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of C$0.31 is trading 27.1% above its estimated GF Value™ of C$0.24. GuruFocus considers Microbix Biosystems to be Modestly Overvalued.

Key valuation signals for TSX:MBX:

ROCE %: -14.50%
GF Value™: C$0.24 vs. price of C$0.31 (27.1% above fair value)
GF Score™: 52/100 with 8 warning signs

No single metric tells the full story. See the TSX:MBX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Industry Healthcare Biotechnology

Comparable Companies TSX:BCT TSX:MDNA TSXV:MIR TSXV:TTI TSXV:GSD XCNQ:DTC TSXV:ARCH TSX:RVX XCNQ:LOBE TSX:SVA VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges MBXBF:USA

Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3

Website https://www.microbix.com

Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.

52GF Score

Get the complete analysis for TSX:MBX

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.31

Price

C$0.24

GF Value

View TSX:MBX Analysis

See ROCE % data for all stocks →